Amlodipine-based fixed-dose combinations — the long-acting dihydropyridine calcium channel blocker paired with ACE inhibitors, ARBs, or statins in single-pill formulations for enhanced blood pressure control and cardiovascular risk reduction — represent the fastest-expanding product category in the global antihypertensive landscape, with the Calcium Channel Blocker Market reflecting...